SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sigachi Industries - Quaterly Results

18 Jan 2025 Evaluate
The sales for the December 2024 quarter moved up 36.76% to Rs. 1050.76 millions as compared to Rs. 768.33 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -10.17% to Rs. 96.77  millions from Rs. 107.72 millions.Operating profit surged to 232.36 millions from the corresponding previous quarter of 174.96 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1050.76 768.33 36.76 2942.93 2338.44 25.85 3175.00 2903.24 9.36
Other Income 20.46 16.84 21.50 183.05 44.08 315.27 115.73 66.72 73.46
PBIDT 232.36 174.96 32.81 738.72 487.29 51.60 708.66 624.85 13.41
Interest 33.57 16.72 100.78 78.56 45.94 71.01 70.20 42.87 63.75
PBDT 198.79 158.24 25.63 660.16 441.35 49.58 638.46 581.98 9.70
Depreciation 39.58 20.62 91.95 89.81 59.86 50.03 87.09 66.21 31.54
PBT 159.21 137.62 15.69 570.35 381.49 49.51 551.37 515.77 6.90
TAX 62.44 29.90 108.83 163.47 88.63 84.44 141.23 100.18 40.98
Deferred Tax 32.13 3.42 839.47 71.89 15.48 364.41 32.08 -2.06 -1657.28
PAT 96.77 107.72 -10.17 406.88 292.86 38.93 410.14 415.59 -1.31
Equity 333.44 323.48 3.08 333.45 323.48 3.08 328.20 307.43 6.76
PBIDTM(%) 22.11 22.77 -2.89 25.10 20.84 20.46 22.32 21.52 3.71

Sigachi Industries Share Price

22.64 0.12 (0.53%)
21-Apr-2026 11:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1667.50
Dr. Reddys Lab 1221.70
Cipla 1231.85
Zydus Lifesciences 929.50
Lupin 2322.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×